Waters Corporation (WAT) EV/Sales Ratio: 9.19x
Is Waters Corporation’s EV/Sales ratio high or low?
Waters Corporation's EV/Sales ratio of 9.19x is 25% above its 5-year average of 7.32x, near the high end of its 5-year range (5.35x–10.35x).
As of Friday, June 12, 2026. 30.61% above its 12-month average of 7.04x.
WAT EV/Sales Ratio Chart
WAT Average EV/Sales Ratio Chart
WAT Current vs Average EV/Sales Ratio Chart
WAT EV/Sales Ratio Metrics
EV/SALES RATIO
9.19x
EV/SALES RATIO AVG TTM
7.04x
EV/SALES RATIO AVG 3Y
7.13x
EV/SALES RATIO AVG 5Y
7.32x
EV/SALES RATIO AVG 10Y
7.09x
EV/SALES RATIO AVG 15Y
6.43x
EV/SALES RATIO AVG 20Y
5.90x
CURRENT VS TTM AVG
+30.61%
CURRENT VS 3Y AVG
+28.87%
CURRENT VS 5Y AVG
+25.49%
CURRENT VS 10Y AVG
+29.70%
CURRENT VS 15Y AVG
+42.88%
CURRENT VS 20Y AVG
+55.76%
WAT Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $23.45B | 9.19x | 7.04x | 7.13x | 7.32x |
| United Therapeutics Corporation (UTHR) | $23.15B | 7.78x | 6.45x | 5.72x | 5.77x |
| Mettler-Toledo International Inc. (MTD) | $23.06B | 6.19x | 7.35x | 7.51x | 8.18x |
| BioNTech SE (BNTX) | $22.52B | 3.50x | 4.19x | 3.71x | 3.47x |
| Veeva Systems Inc. (VEEV) | $26.24B | 7.54x | 12.47x | 13.32x | 15.68x |
| Moderna, Inc. (MRNA) | $19.70B | 8.54x | 5.96x | 5.02x | 6.82x |
| DexCom, Inc. (DXCM) | $29.04B | 6.20x | 6.63x | 10.22x | 13.87x |
| Biogen Inc. (BIIB) | $29.52B | 3.33x | 2.79x | 3.30x | 3.58x |
| Hologic, Inc. (HOLX) | $16.97B | 4.25x | 4.02x | 4.39x | 4.15x |
| IQVIA Holdings Inc. (IQV) | $30.22B | 1.86x | 2.83x | 3.22x | 3.53x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Waters Corporation EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Waters Corporation EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Waters Corporation (WAT)?
- The EV/Sales ratio for WAT stock is 9.19x.
- Is Waters Corporation's EV/Sales ratio high or low?
- Waters Corporation's EV/Sales ratio of 9.19x is 25% above its 5-year average of 7.32x, near the high end of its 5-year range (5.35x–10.35x).
- What is the TTM average EV/Sales ratio for Waters Corporation (WAT)?
- The TTM average EV/Sales ratio for WAT stock is 7.04x.
- What is the 3Y average EV/Sales ratio for Waters Corporation (WAT)?
- The 3Y average EV/Sales ratio for WAT stock is 7.13x.
- What is the 5Y average EV/Sales ratio for Waters Corporation (WAT)?
- The 5Y average EV/Sales ratio for WAT stock is 7.32x.
- What is the 10Y average EV/Sales ratio for Waters Corporation (WAT)?
- The 10Y average EV/Sales ratio for WAT stock is 7.09x.
- What is the 15Y average EV/Sales ratio for Waters Corporation (WAT)?
- The 15Y average EV/Sales ratio for WAT stock is 6.43x.
- What is the 20Y average EV/Sales ratio for Waters Corporation (WAT)?
- The 20Y average EV/Sales ratio for WAT stock is 5.90x.
Waters Corporation EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-11 | 9.19x |
| 2026-06-10 | 9.27x |
| 2026-06-09 | 9.44x |
| 2026-06-08 | 9.27x |
| 2026-06-05 | 9.31x |
| 2026-06-04 | 9.56x |
| 2026-06-03 | 9.63x |
| 2026-06-02 | 9.46x |
| 2026-06-01 | 9.59x |
| 2026-05-29 | 9.71x |
| 2026-05-28 | 9.34x |
| 2026-05-27 | 8.81x |
| 2026-05-26 | 8.73x |
| 2026-05-22 | 8.81x |
| 2026-05-21 | 8.78x |
| 2026-05-20 | 8.79x |
| 2026-05-19 | 8.61x |
| 2026-05-18 | 8.59x |
| 2026-05-15 | 8.53x |
| 2026-05-14 | 8.61x |
| 2026-05-13 | 8.65x |
| 2026-05-12 | 9.03x |
| 2026-05-11 | 6.86x |
| 2026-05-08 | 6.99x |
| 2026-05-07 | 6.90x |
| 2026-05-06 | 6.88x |
| 2026-05-05 | 6.75x |
| 2026-05-04 | 5.99x |
| 2026-05-01 | 6.08x |
| 2026-04-30 | 6.12x |
| 2026-04-29 | 5.80x |
| 2026-04-28 | 5.96x |
| 2026-04-27 | 5.95x |
| 2026-04-24 | 6.14x |
| 2026-04-23 | 6.16x |
| 2026-04-22 | 6.60x |
| 2026-04-21 | 6.61x |
| 2026-04-20 | 6.62x |
| 2026-04-17 | 6.47x |
| 2026-04-16 | 6.31x |
| 2026-04-15 | 6.44x |
| 2026-04-14 | 6.53x |
| 2026-04-13 | 6.42x |
| 2026-04-10 | 6.33x |
| 2026-04-09 | 6.28x |
| 2026-04-08 | 6.30x |
| 2026-04-07 | 6.09x |
| 2026-04-06 | 6.03x |
| 2026-04-02 | 6.03x |
| 2026-04-01 | 5.95x |
| 2026-03-31 | 5.91x |
| 2026-03-30 | 5.82x |
| 2026-03-27 | 5.74x |
| 2026-03-26 | 5.96x |
| 2026-03-25 | 5.99x |
| 2026-03-24 | 5.99x |
| 2026-03-23 | 5.98x |
| 2026-03-20 | 5.93x |
| 2026-03-19 | 5.94x |
| 2026-03-18 | 5.86x |
| 2026-03-17 | 5.89x |
| 2026-03-16 | 5.76x |
| 2026-03-13 | 5.70x |
| 2026-03-12 | 5.63x |
| 2026-03-11 | 5.90x |
| 2026-03-10 | 5.94x |
| 2026-03-09 | 6.06x |
| 2026-03-06 | 6.00x |
| 2026-03-05 | 6.24x |
| 2026-03-04 | 6.31x |
| 2026-03-03 | 6.18x |
| 2026-03-02 | 6.09x |
| 2026-02-27 | 6.32x |
| 2026-02-26 | 6.38x |
| 2026-02-25 | 6.32x |
| 2026-02-24 | 6.45x |
| 2026-02-23 | 6.47x |
| 2026-02-20 | 6.73x |
| 2026-02-19 | 6.64x |
| 2026-02-18 | 6.62x |
| 2026-02-17 | 6.50x |
| 2026-02-13 | 6.54x |
| 2026-02-12 | 6.47x |
| 2026-02-11 | 6.65x |
| 2026-02-10 | 6.61x |
| 2026-02-09 | 6.63x |
| 2026-02-06 | 7.65x |
| 2026-02-05 | 7.57x |
| 2026-02-04 | 7.71x |
| 2026-02-03 | 7.61x |
| 2026-02-02 | 7.61x |
| 2026-01-30 | 7.45x |
| 2026-01-29 | 7.53x |
| 2026-01-28 | 7.72x |
| 2026-01-27 | 7.82x |
| 2026-01-26 | 7.84x |
| 2026-01-23 | 7.86x |
| 2026-01-22 | 8.02x |
| 2026-01-21 | 7.95x |
| 2026-01-20 | 7.70x |
| 2026-01-16 | 7.77x |
| 2026-01-15 | 7.91x |
| 2026-01-14 | 7.88x |
| 2026-01-13 | 7.90x |
| 2026-01-12 | 7.89x |
| 2026-01-09 | 7.95x |
| 2026-01-08 | 7.95x |
| 2026-01-07 | 8.00x |
| 2026-01-06 | 8.02x |
| 2026-01-05 | 7.91x |
| 2026-01-02 | 7.66x |
| 2025-12-31 | 7.62x |
| 2025-12-30 | 7.70x |
| 2025-12-29 | 7.72x |
| 2025-12-26 | 7.74x |
| 2025-12-24 | 7.72x |
| 2025-12-23 | 7.69x |
| 2025-12-22 | 7.71x |
| 2025-12-19 | 7.59x |
| 2025-12-18 | 7.56x |
| 2025-12-17 | 7.57x |
| 2025-12-16 | 7.60x |
| 2025-12-15 | 7.73x |
| 2025-12-12 | 7.73x |
| 2025-12-11 | 7.86x |
| 2025-12-10 | 7.93x |
| 2025-12-09 | 7.74x |
| 2025-12-08 | 7.87x |
| 2025-12-05 | 7.91x |
| 2025-12-04 | 7.94x |
| 2025-12-03 | 7.96x |
| 2025-12-02 | 7.98x |
| 2025-12-01 | 7.97x |
| 2025-11-28 | 8.08x |
| 2025-11-26 | 8.15x |
| 2025-11-25 | 8.25x |
| 2025-11-24 | 8.00x |
| 2025-11-21 | 7.89x |
| 2025-11-20 | 7.60x |
| 2025-11-19 | 7.55x |
| 2025-11-18 | 7.56x |
| 2025-11-17 | 7.59x |
| 2025-11-14 | 7.61x |
| 2025-11-13 | 7.61x |
| 2025-11-12 | 7.77x |
| 2025-11-11 | 7.74x |
| 2025-11-10 | 7.56x |
| 2025-11-07 | 7.47x |
| 2025-11-06 | 7.46x |
| 2025-11-05 | 7.47x |
| 2025-11-04 | 7.38x |
| 2025-11-03 | 7.15x |
| 2025-10-31 | 7.23x |
| 2025-10-30 | 7.10x |
| 2025-10-29 | 7.11x |
| 2025-10-28 | 7.16x |
| 2025-10-27 | 7.27x |
| 2025-10-24 | 7.43x |
| 2025-10-23 | 7.35x |
| 2025-10-22 | 7.21x |
| 2025-10-21 | 7.22x |
| 2025-10-20 | 7.11x |
| 2025-10-17 | 6.94x |
| 2025-10-16 | 6.94x |
| 2025-10-15 | 6.89x |
| 2025-10-14 | 6.91x |
| 2025-10-13 | 6.97x |
| 2025-10-10 | 6.87x |
| 2025-10-09 | 6.86x |
| 2025-10-08 | 6.80x |
| 2025-10-07 | 6.62x |
| 2025-10-06 | 6.80x |
| 2025-10-03 | 6.82x |
| 2025-10-02 | 6.69x |
| 2025-10-01 | 6.65x |
| 2025-09-30 | 6.26x |
| 2025-09-29 | 6.05x |
| 2025-09-26 | 6.10x |
| 2025-09-25 | 6.02x |
| 2025-09-24 | 6.12x |
| 2025-09-23 | 6.24x |
| 2025-09-22 | 6.31x |
| 2025-09-19 | 6.28x |
| 2025-09-18 | 6.38x |
| 2025-09-17 | 6.33x |
| 2025-09-16 | 6.32x |
| 2025-09-15 | 6.24x |
| 2025-09-12 | 6.17x |
| 2025-09-11 | 6.31x |
| 2025-09-10 | 6.12x |
| 2025-09-09 | 6.27x |
| 2025-09-08 | 6.44x |
| 2025-09-05 | 6.38x |
| 2025-09-04 | 6.25x |
| 2025-09-03 | 6.07x |
| 2025-09-02 | 6.19x |
| 2025-08-29 | 6.30x |
| 2025-08-28 | 6.21x |
| 2025-08-27 | 6.15x |
| 2025-08-26 | 6.18x |
| 2025-08-25 | 6.24x |
| 2025-08-22 | 6.30x |
| 2025-08-21 | 6.07x |
| 2025-08-20 | 6.20x |
| 2025-08-19 | 6.22x |
| 2025-08-18 | 6.05x |
| 2025-08-15 | 6.09x |
| 2025-08-14 | 6.13x |
| 2025-08-13 | 6.20x |
| 2025-08-12 | 5.98x |
| 2025-08-11 | 5.85x |
| 2025-08-08 | 5.89x |
| 2025-08-07 | 5.83x |
| 2025-08-06 | 5.82x |
| 2025-08-05 | 5.89x |
| 2025-08-04 | 5.98x |
| 2025-08-01 | 6.20x |
| 2025-07-31 | 6.17x |
| 2025-07-30 | 6.37x |
| 2025-07-29 | 6.46x |
| 2025-07-28 | 6.44x |
| 2025-07-25 | 6.45x |
| 2025-07-24 | 6.36x |
| 2025-07-23 | 6.30x |
| 2025-07-22 | 6.14x |
| 2025-07-21 | 6.02x |
| 2025-07-18 | 6.14x |
| 2025-07-17 | 6.33x |
| 2025-07-16 | 6.18x |
| 2025-07-15 | 6.18x |
| 2025-07-14 | 6.47x |
| 2025-07-11 | 7.45x |
| 2025-07-10 | 7.46x |
| 2025-07-09 | 7.38x |
| 2025-07-08 | 7.35x |
| 2025-07-07 | 7.33x |
| 2025-07-03 | 7.40x |
| 2025-07-02 | 7.43x |
| 2025-07-01 | 7.53x |
| 2025-06-30 | 7.37x |
| 2025-06-27 | 7.44x |
| 2025-06-26 | 7.49x |
| 2025-06-25 | 7.39x |
| 2025-06-24 | 7.33x |
| 2025-06-23 | 7.25x |
| 2025-06-20 | 7.24x |
| 2025-06-18 | 7.18x |
| 2025-06-17 | 7.21x |
| 2025-06-16 | 7.35x |
| 2025-06-13 | 7.24x |
| 2025-06-12 | 7.38x |
| 2025-06-11 | 7.31x |
| 2025-06-10 | 7.39x |
| 2025-06-09 | 7.36x |
| 2025-06-06 | 7.42x |
| 2025-06-05 | 7.32x |
| 2025-06-04 | 7.46x |
| 2025-06-03 | 7.38x |
| 2025-06-02 | 7.27x |
| 2025-05-30 | 7.38x |
Showing the most recent 260 of 5,032 data points. The chart above shows the full history.
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra